According to some research, it is indicated that only a fraction of 40% of American have invested in stock exchange while the rest are still learning how to trade in the stock exchange yet they are not sure and do not know where to start. It is known that investing is taking risk and the beat risk is taken after consulting with professionals who give advice on investing in stock exchange. Paul Mampilly is referred to a guru when it comes to trading in the stock exchange market and he has the major responsibility of providing powerful investing advice.
Paul Mampilly is an American investor who for a long time has been offering investment advice to not only Americans but also to the world. He has majored his advice on stock exchange trading. To be able to reach a wide range of individuals through his investing advice; Paul established a newsletter known as Profit Unlimited. The media platform has been expanding ever since it was founded and has over 90000 subscribers from all over the world. Paul Mampilly has benefited thousands of individuals across the globe to reach their goals as they invest wisely.
Mr. Paul was not born in the United States of America; he was born in India and relocated to the United States of America as a young man. Moving to the country had a great advantage to the prominent investor who was determined to learn more as well as gain skills in investments, finances as well as Wall Street in general. Paul Mampilly has a vast knowledge in the investing sector which runs for more than 25 years. He began his career serving at Banker’s Trust. He later served in several other financial facilities holding different leadership positions. Some of the financial institutions Mr. Paul served include; Deutsche Bank, Royal Bank of Scotland, ING, and other private financial organizations. M r. Paul Mampilly has not only been successful in assisting others to meet their personal and long-term goals and dreams in the investment world, but he is a prominent investor who has done well in his personal investments as well. Paul has invested in the pharmaceutical sector; Sarepta Therapeutic. Paul is a graduate of Montclair State University, New Jersey.